Literature DB >> 27108244

Targeting HER2: precision oncology for colorectal cancer.

Hans-Joachim Schmoll1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27108244     DOI： 10.1016/S1470-2045(16)30039-0

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  2 in total

1.  HER2 status in patients with residual rectal cancer after preoperative chemoradiotherapy: the relationship with molecular results and clinicopathologic features.

Authors:  Jun Seok Park; Ghilsuk Yoon; Hye Jin Kim; Soo Yeun Park; Gyu Seog Choi; Min Kyu Kang; Jong Gwang Kim; Jung-Sik Jang; An Na Seo
Journal:  Virchows Arch       Date:  2018-07-28       Impact factor: 4.064

Review 2.  Molecular Testing for Gastrointestinal Cancer.

Authors:  Hye Seung Lee; Woo Ho Kim; Yoonjin Kwak; Jiwon Koh; Jeong Mo Bae; Kyoung-Mee Kim; Mee Soo Chang; Hye Seung Han; Joon Mee Kim; Hwal Woong Kim; Hee Kyung Chang; Young Hee Choi; Ji Y Park; Mi Jin Gu; Min Jin Lhee; Jung Yeon Kim; Hee Sung Kim; Mee-Yon Cho
Journal:  J Pathol Transl Med       Date:  2017-02-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.